ABOUT US

Treating tumors quickly, safely and effectively

IceCure is setting new standards in minimally-invasive tumor therapy for women’s health and interventional oncology.

IceCure Medical is an Israeli medical device company founded in 2006 to advance treatment of cancerous tumors. IceCure’s core technology is based on cryoablation, using freezing temperature (liquid nitrogen) to destroy tumors safely, quickly, and painlessly without the need for surgery.

IceCure’s next generation cryoablation technology, the ProSense™ system, enables rapid minimally-invasive, safe, and effective treatment of breast lesions in-office or ambulatory hospital settings.

The ProSense™ system provides physicians with full control over the procedure, ensuring that the treated zone is destroyed while leaving surrounding tissue undamaged.

The ProSense™ system is a proven solution for the treatment of benign and malignant breast tumors, as well as renal, lung, and bone cancer.
IceCure’s team leaders are seasoned medical device and technology entrepreneurs, who have teamed with world-renowned academics, clinical centers, and practitioners to establish advanced cryotherapy as the standard in oncology clinics worldwide.

In October 2018, the American Association of Breast Surgeons adapted its guidelines following the ProSense ICE3 trial, supporting accelerated investigations of cryoablation technology for treatment of malignant breast tumors

Unique technology and powerful IP
27 approved and pending patents

FDA cleared, CE marked
For minimally-invasive cryoablation applications

THE TEAM

RON MAYRON

RON MAYRON
CHAIRMAN OF THE BOARD

Chairman and director of several public and privately owned companies, primarily focusing on the medical device industry. Ron held various senior positions at Teva over the course of 20 years, including CEO Teva Israel and VP Israel & Africa.

EYAL SHAMIR

EYAL SHAMIR
CEO

Prior to joining IceCure, Eyal served as CEO of medical device and export companies, including B-Cure Laser and Hanita Lenses. Eyal is a seasoned executive and has extensive experience in global business development, particularly China and Japan.

ELISABETH SADKA

ELISABETH SADKA 
VP RA/QA & CLINICAL APPLICATIONS

Elisabeth brings over 20 years of experience in quality, regulation and clinical management positions at medical device companies, including Galil Medical, CutMed, and BioScan.

TLALIT BUSSI TEL-TZURE

TLALIT BUSSI TEL-TZURE
VP BUSINESS DEVELOPMENT & GLOBAL MARKETING

Tlalit has served in senior sales, business development and marketing positions within the healthcare industry for over 18 years, including key roles at DiA Imaging Analysis, Medical Compression Systems, Chemitec, and Trima.

RONEN TSIMERMAN

RONEN TSIMERMAN
CFO & COO

Ronen has over 15 years of experience as CFO in public and privately held companies in the medical device and communication infrastructure industries, including C. Mer Telecom Division and Insuline Medical.

NAUM MUCHNIK

NAUM MUCHNIK
VP R&D and Engineering

Naum has 15 years of professional experience developing a diverse range of medical device products. He previously served as R&D Mech. Manager at GE Healthcare CardioVascular & POC Ultrasound, and OP&S Manager at Medasense Biometrics.